Discover
DWTX
Dogwood Therapeutics, Inc.
1.50
2 x 1.13
2 x 1.89
bid
ask
-
0.11
6.83%
2 @ 05:23 AM
1.63 +0.13 (8.96%)
| Ytd | -63.94% | |
| 1y | -69.70% |
1.49
day range
1.64
1.28
52 week range
9.50
| Open | 1.64 | Prev Close | 1.61 | Low | 1.49 | High | 1.64 | Mkt Cap | 50.44M |
| Vol | 135.85K | Avg Vol | 103.02K | EPS | 1.17 | P/E | 1.28 | Forward P/E | -0.43 |
| Beta | 1.57 | Short Ratio | 0.42 | Inst. Own | 3.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.60 | 200-d Avg | 3.63 | 1yr Est | 13.83 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-07 | 2024-09 | -1.33 | -2.05 | -0.72 | -54.14% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-08-16 | DUNCAN GREGORY SCOTT | Chief Executive Officer | 57.46K | Purchase |
| 2023-08-20 | PRIDGEN WILLIAM L | Director | 0.00 | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Geode Capital Management, LLC | 18.46K | 50.21K | 1.39% |
| 2024-09-29 | Vanguard Group Inc | 16.71K | 45.45K | 1.25% |
| 2024-09-29 | UBS Group AG | 14.89K | 40.49K | 1.12% |
| 2024-09-29 | HRT Financial LP | 6.53K | 17.75K | 0.49% |
| 2024-09-29 | State Street Corporation | 4.23K | 11.49K | 0.32% |
| 2024-09-29 | Two Sigma Securities, LLC | 4.27K | 11.62K | 0.32% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 16.71K | 45.45K | 1.25% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 5.94K | 16.16K | 0.45% |
| 2024-10-30 | Fidelity Total Market Index Fund | 2.29K | 6.24K | 0.17% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 1.75K | 4.76K | 0.13% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 880.00 | 2.39K | 0.07% |